We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+11.21%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$32.7B
AUM Growth
+$4.24B
(+15%)
Cap. Flow
+$1.96B
Cap. Flow
% of AUM
5.98%
Top 10 Holdings %
Top 10 Hldgs %
24.15%
Holding
1,955
New
105
Increased
595
Reduced
1,083
Closed
168
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$183M |
| 2 |
J.M. Smucker
SJM
|
+$174M |
| 3 |
C.H. Robinson
CHRW
|
+$169M |
| 4 |
Microsoft
MSFT
|
+$165M |
| 5 |
Nordson
NDSN
|
+$161M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VF Corp
VFC
|
+$153M |
| 2 |
Caterpillar
CAT
|
+$44.2M |
| 3 |
Franklin Resources
BEN
|
+$41.9M |
| 4 |
Air Products & Chemicals
APD
|
+$35.1M |
| 5 |
Pentair
PNR
|
+$32.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.57% |
| 2 | Industrials | 11.94% |
| 3 | Consumer Staples | 11.7% |
| 4 | Consumer Discretionary | 10.33% |
| 5 | Healthcare | 10.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESPR
1726
DELISTED
Esperion Therapeutics
ESPR
| $22.2K | ﹤0.01% |
13,989
-1,594
| -10% | -$8.23K |
|
1727
Blend Labs
BLND
$409M
| $22.2K | ﹤0.01% |
22,281
-2,077
| -9% | -$3.18K |
|
|
FIRY
1728
Firy Inc
FIRY
$127M
| $21.9K | ﹤0.01% |
1,849
-173
| -9% | -$2.29K |
|
1729
Ocugen
OCGN
$410M
| $21.8K | ﹤0.01% |
25,570
-2,383
| -9% | -$2.6K |
|
|
GOEV
1730
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $21.8K | ﹤0.01% |
73
+26
| +55% | +$11K |
|
|
FFAI
1731
Faraday Future Intelligent Electric
FFAI
$15.8M
| – | – |
0
| – | – |
|
1732
Ring Energy
REI
$322M
| $21.1K | ﹤0.01% |
11,096
-1,035
| -9% | -$2.23K |
|
1733
Ginkgo Bioworks
DNA
$481M
| $20.9K | ﹤0.01% |
393
-592
| -60% | -$37.5K |
|
1734
AtaiBeckley Inc
ATAI
$2.66B
| $20.8K | ﹤0.01% |
11,500
-2,219
| -16% | -$3.76K |
|
1735
Outdoor Holding Co
POWW
$239M
| $20.5K | ﹤0.01% |
10,413
-970
| -9% | -$2K |
|
|
AFMD
1736
DELISTED
Affimed
AFMD
| $20.2K | ﹤0.01% |
2,709
-399
| -13% | -$3.99K |
|
1737
Outlook Therapeutics
OTLK
$264M
| $19.8K | ﹤0.01% |
910
+148
| +19% | +$3.31K |
|
1738
BARK
BARK
$74.8M
| $18.5K | ﹤0.01% |
+638
| New | +$20.2K |
|
1739
Heron Therapeutics
HRTX
$86.3M
| $18.3K | ﹤0.01% |
12,112
-1,130
| -9% | -$2.83K |
|
|
FSP
1740
Franklin Street Properties
FSP
$44.8M
| $18.2K | ﹤0.01% |
11,623
-3,762
| -24% | -$9.45K |
|
1741
Gossamer Bio
GOSS
$66.5M
| $17.6K | ﹤0.01% |
13,963
-1,955
| -12% | -$3.74K |
|
|
CANO
1742
DELISTED
Cano Health, Inc.
CANO
| $17.3K | ﹤0.01% |
191
-17
| -8% | -$2.31K |
|
|
SOND
1743
DELISTED
Sonder
SOND
| $16.9K | ﹤0.01% |
1,115
-103
| -8% | -$2.39K |
|
1744
Amneal Pharmaceuticals
AMRX
$5.72B
| $16.8K | ﹤0.01% |
12,121
-1,132
| -9% | -$2.25K |
|
|
CRGE
1745
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
| $16.8K | ﹤0.01% |
15,311
-1,427
| -9% | -$1.8K |
|
1746
Invivyd
IVVD
$180M
| $16.3K | ﹤0.01% |
13,597
-2,022
| -13% | -$3.69K |
|
|
BINI
1747
DELISTED
Bollinger Innovations
BINI
| – | – |
0
| – | – |
|
1748
Cartesian Therapeutics
RNAC
$232M
| $14.7K | ﹤0.01% |
354
-68
| -16% | -$3.2K |
|
|
XXII
1749
22nd Century Group
XXII
$1.47M
| – | – |
0
| – | – |
|
|
RIDE
1750
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
| $13.8K | ﹤0.01% |
1,383
-129
| -9% | -$2.04K |
|
Similar funds
ProShare Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, ProShare Advisors held 1,955 positions worth $32.7B, up 15% from $28.5B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
ProShare Advisors deployed $1.96B of net new capital in Q1 2023, opening 105 new positions and adding to 595 existing holdings. Its largest new stake was Target: 1,112,637 shares worth $184M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Industrials and Consumer Staples.
On the sell side, the largest reduction was VF Corp, an estimated $153M trimmed.
- ProShare Advisors's largest Q1 2023 buy was Target: 1,112,637 shares worth $184M.
- ProShare Advisors added most to J.M. Smucker in Q1 2023, an estimated $174M increase.
- ProShare Advisors's biggest Q1 2023 reduction was VF Corp, cutting an estimated $153M.
- ProShare Advisors fully exited South Jersey Industries, Inc. in Q1 2023, selling an estimated $10.2M.
- ProShare Advisors's ten largest holdings make up 24% of its $32.7B portfolio in Q1 2023.
- ProShare Advisors opened 105 new positions and closed 168 in Q1 2023.
- ProShare Advisors's portfolio value rose 15% quarter-over-quarter to $32.7B.
Based on ProShare Advisors's 13F filing for Q1 2023, filed 12 May 2023.